Botulinum toxin for the treatment of refractory erythema and flushing of rosacea

Dermatology. 2015;230(4):299-301. doi: 10.1159/000368773. Epub 2015 Mar 3.

Abstract

Background: Persistent erythema and severe rosacea flushing can cause significant physical discomfort and emotional stress to patients. Currently, no satisfactory treatments are available.

Methods: We report two cases of refractory flushing and erythema of rosacea that were successfully treated with intradermal botulinum toxin injections.

Results: Good cosmetic results were achieved for both patients. The side effects during and after treatment were mild pain and localized bruising; these symptoms resolved within several days without further treatment.

Conclusion: Intradermal botulinum toxin injection may be an effective treatment for refractory erythema and rosacea flushing that deserves further study in a larger patient population.

Publication types

  • Case Reports

MeSH terms

  • Acetylcholine Release Inhibitors / administration & dosage
  • Acetylcholine Release Inhibitors / therapeutic use*
  • Adult
  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / therapeutic use*
  • Erythema / drug therapy*
  • Erythema / etiology
  • Female
  • Flushing / drug therapy*
  • Flushing / etiology
  • Humans
  • Injections, Intradermal
  • Middle Aged
  • Retreatment
  • Rosacea / complications
  • Rosacea / drug therapy*

Substances

  • Acetylcholine Release Inhibitors
  • Botulinum Toxins, Type A